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Abstract 
Hydrophilic polymers are frequently employed to develop matrices for controlled release 
applications. The physicochemical properties of these polymeric materials can have an impact 
on their compaction behaviour. Hence, the degree and extent of deformation and consolidation 
of these polymers can influence the compaction pressure dependant attributes that include, but 
are not limited to, porosity, surface roughness, compact internal microstructure and 
interparticulate bonding and packing. It is anticipated that these aforementioned tabletting 
attributes could influence the performance and functionality of hydrophilic matrices, although 
limited studies have been conducted in this regard. Therefore, two polymers hydroxypropyl 
methylcellulose (HPMC K4M), polyethylene oxide (PEO WSR N60K) and their mixture (1:1 
w/w) were selected. These polymers have appreciable different compression properties but 
comparable molecular size and this study was carried out to understand the role of tabletting 
attributes on swelling and erosion characteristics. It is evident from the findings that the 
changes in compression pressure affect the tensile strength, porosity, bulk and apparent density, 
microstructural properties, bonding strength and surface roughness of all types of matrix 
tablets. Increase in compression pressure has monotonically enhanced the swelling rate and 
degree of erosion of the matrix tablets, however, in the case of HPMC K4M and HPMC K4M: 
PEO WSR N60K (1:1 w/w) based matrices the swelling and erosion rate become steady after 
150 MPa compression pressure. All the tabletting attributes such as swelling and erosion rate, 
average pore diameter, surface roughness and interparticulate bonding capacity are inter-linked 
(mostly R2 lies in the range of 0.74 - 0.99 ) and greatly affect each other. It can be concluded 
from the findings that a careful comprehension of tableting attributes associated with 
compressed matrix tablets might be valuable in developing successful hydrophilic matrices for 
control drug release applications.  
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1- Introduction 
The oral route is undoubtedly the most prevalent drug administration route among patients and 
physicians. The oral drug delivery market represents 52% of the overall drug delivery market 
with an approximate value of $49 billion in 2012 and $90 billion in 2016 worldwide (MP-
Advisors, 2014). This rapid growth is primarily driven by the development and introduction of 
new controlled release formulations (De Robertis et al., 2015) including osmotic controlled 
pumps, reservoir devices and monolithic matrix systems. Monolithic systems are polymeric 
matrices in which active pharmaceutical ingredient (API) can be present in dispersed or 
dissolved form. These systems can be developed using hydrophilic or hydrophobic polymers.  
1.1- Hydrophilic matrix system 
A hydrophilic matrix is a monolithic system in which hydrophilic polymers are employed as 
drug release retardants. It is one of the most attractive controlled drug delivery systems 
(Alderman et al., 1984; Maderuelo et al., 2011; Ghori and Conway, 2015) with advantages 
including simple technology, cost effectiveness, reliability and flexibility (Li et al., 2005; 
Maderuelo et al., 2011). In addition, formulations are easy to manufacture and most importantly 
the drug can be released continuously over a prolonged period of time and steady drug plasma 
levels can be achieved. Hydrophilic matrix systems can further lead to a decrease in a patient 
to patient bioavailability variation during drug administration. Moreover, this system can 
reduce the total number of doses as well as possible side effects related to high drug plasma 
levels (De Robertis et al., 2015). 
It is a mixture of drug molecules in which one or several other pharmaceutical adjuvants are 
embedded with hydrophilic polymer. Examples of pharmaceutically relevant hydrophilic 
polymers include cellulose ethers, xanthan gum, polyethylene oxide, sodium alginates and 
Carbopol®. Amongst these, cellulose ether derivatives, particularly methyl cellulose (MC), 
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HPMC K4M (hydroxypropyl methylcellulose HPMC K4M) and hydroxypropylcellulose 
(HPC) have been of particular interest (Li et al., 2005; Maderuelo et al., 2011; Ghori and 
Conway, 2015). Also, polyethylene oxide (PEO WSR N60K), particularly high molecular 
weight, has been successfully employed in the formulation of hydrophilic matrices over the 
past decade. For all the polymers above, their broad spectrum of acceptance can be attributed 
to their non-toxic nature, availability in different grades and good regulatory acceptance (Ma 
et al., 2014). Generally hydrophilic matrices are manufactured using compression, hence, the 
term matrix tablets is widely used in literature (Ghori 2014). Most of the aforementioned 
hydrophilic polymers have fairly good compression properties, therefore, these matrices can 
often be prepared by direct compression (Wen et al., 2010). The fundamental operations 
involved in the preparation of these compressed hydrophilic matrices are not different from the 
ones involved in the manufacturing of conventional tablets, such as mixing and compression 
of ingredients  
1.2- Mechanism of swelling, erosion and drug release 
Polymer swelling, diffusion, drug dissolution, front movement and erosion of matrices all 
contribute towards the release of drug at molecular or microscopic level. When these 
hydrophilic matrices are exposed to biological fluids, a steep fluid concentration gradient is 
formed between the outermost surface of matrix tablet and fluid (Caraballo 2010). Hence, fluid 
is imbibed into the polymer matrix network. The fluid acts as a plasticiser and the glass 
transition temperature [(Tg) a transition of a material from a hard and relatively brittle glassy 
state to a rubbery state] reduces to 37 °C and the polymer chains start to relax and eventually 
disentangle increasing the molecular surface area (Colombo et al., 1999; Colombo et al., 2000; 
Maderuelo et al., 2011). This phenomenon of polymer chain relaxation is termed ‘swelling’ 
and the continuous inward ingression of liquid breaks the hydrogen bonds formed during tablet 
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compaction and can lead to the development of new hydrogen bonds accommodating water 
molecules. Therefore, the reduction in Tg and formation of new hydrogen bonds results in the 
swelling of polymer chains. Hence, a thick gelatinous layer appears on the surface of matrix 
tablets, as hydrophilic polymer passes from the amorphous glassy state to the rubbery state. 
Over a period of time, additional water enters the system and consequently the thickness of the 
gel layer increases (Ghori and Conway, 2015). The formation of the gel layer and penetration 
(diffusion) of the medium into the matrix is accompanied by the development of a series of 
various regions on the surface of matrix tablet. Four distinguishable regions are the erosion 
front, dissolution front, penetration front and swelling front as illustrated in Figure 1.1, (Ghori 
2014).  
The whole process of drug release is complicated and involves various steps: first of all entry 
of the aqueous medium into the matrix; secondly swelling of the matrix and dissolution of the 
drug in the medium; thirdly diffusion of the drug through the gel layer and finally erosion of 
the swollen matrix. Most of the time both diffusion and erosion occur simultaneously. Four 
various types of release mechanisms have been categorised which depend on the 
aforementioned processes (Maderuelo et al., 2011). 
 Fickian diffusion: The process which controls the release of APIs. 
 Polymer swelling: Swelling of the polymer determines drug release. 
 Polymer swelling and polymer and drug dissolution: API release depends 
simultaneously on swelling of the matrix and phenomena of diffusion. 
 Polymer erosion: A complete hydrated layer at the surface within the dissolution 
medium which continues to erode. 
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Figure 1.1: Hydrated hydrophilic matrix tablet representing various zones.(adapted from 
Ghori et al., 2014). 
1.3- Hydrophilic polymers 
1.3.1- Hydroxypropyl methylcellulose (HPMC) 
Hydroxypropyl methylcellulose (HPMC) is a semisynthetic, viscoelastic inert polymer 
available in several grades that differ in viscosity and extent of substitution (Rowe et al., 2012). 
Figure 1.2 shows the chemical structure of HPMC. 
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Figure 1.2: Chemical structure of HPMC, where R is H, CH3 or CH2 CH(OH)CH3  (Rowe et 
al., 2006).  
 It is widely used in the formulation of pharmaceutical products as an excipient and an 
important component of controlled delivery in oral formulations (Wertz et al., 2010). HPMC 
comprises cellulose ethers which are soluble in cold water and form a viscous colloidal 
solution. HPMC K4M is practically insoluble in chloroform, ether, ethanol (95%) and hot 
water, however, it is soluble in mixtures of methanol and dichloromethane, mixtures of ethanol 
and dichloromethane and mixtures of water and alcohol. It is a white or creamy white fibril 
powder, which is odourless and tasteless.  
 HPMC polymers for hydrophilic matrix systems are available in different viscosity grades 
ranging from 4000 – 100,000 cps. A wide range of viscosity grades available is commercially 
and one of most commonly used grades is Methocel K4M; this has an apparent viscosity of 
4000 cps at 20°C for a 2% w/v polymer solution (Rowe et al., 2006). Molecular weights 
available for HPMC generally range from 10 000 – 1 500 000 Da (Dow 2002).   
1.3.2- Pharmaceutical applications of HPMC  
Hydroxypropyl methylcellulose (HPMC) is used in the pharmaceutical industry for multiple 
purposes, some of these are described below and summarised in Table 1.1.  
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Table 1.1: Summary of pharmaceutical applications of HPMC. 
Application 
 
Effect 
 
Reference 
 
 
Tablet binders 
 
 
Coating agent 
 
 
 
 
Compressibility  
Enhancer 
 
 
 
Extended release 
excipient 
 
 
 
Ophthalmic 
preparations 
 
 
 
HPMC bind the excipients and drug 
during wet and dry granulation process. 
 
Frequently used in solid dosage forms to 
mask the taste and to protect the sensitive 
drugs. 
 
 
Excellent properties of compaction flow 
during granulation, particularly during 
direct compression. 
 
 
Good compression properties at different 
concentration to control or extend the 
drug release rate. 
 
 
Used as a stabilizer and thickening agent 
plus decrease surface tension. 
 
(Chowhan et al., 1996;  
Itiola, 1991) 
 
Banker et al., 1981; 
Wen et al., 2010 
 
 
 
Shokri et al., 2013;  
Ghori et al., 2014 
 
 
 
Maderuelo et al., 2011 
Li et al., 2005 
 
 
 
Liu et al., 2008; 
 
 
a) Applications as tablet binders 
HPMC exhibits good binding properties for the formation of tablets and capsules (Itiola, 1991; 
Chowhan et al., 1996). The ability to bind the excipients and drug in moist and dry conditions 
throughout compression is one of the fundamental uses of HPMC in the pharmaceutical 
industry (Rowe et al., 2006). 
b) Applications as a coating agent 
Solid dosage forms such as tablets, granules, pellets and microcapsules are frequently coated 
for different reasons, for example to mask the taste, to protect sensitive drugs from certain 
environmental circumstances and humidity or to control drug release over a specific period of 
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time (Wen et al., 2010). HPMC has excellent film-forming properties and widely used for 
coating solid dosage forms (Banker et al., 1981).  
c) Applications as compressibility enhancers 
The majority of pharmaceutical products are administered in tablet form. Tablets can be 
manufactured in different ways but direct compression is a simple, convenient, and efficient 
tablet compression method. Usually this technique is used for tableting when the drug 
concentration is less than 30% w/w of the formulation for medium to high potency of drugs 
(Shokri et al., 2013). Unfortunately, one of the common problems during dry granulation is 
poor powder flow of drugs, particularly when the drug content is more than 30% w/w. To 
overcome this issue cellulose ether like HPMC K4M can be employed as they can significantly 
increase the compressibility of poorly compactable powder mixtures (Ghori et al., 2014b). 
d) Ophthalmic applications 
HPMC is used as a stabiliser and thickening agent for ophthalmic preparations, mainly 
solutions (eye drops and contact lenses) and ointments. HPMC’s role is to decrease surface 
tension which in turn improves wetting and enhances the spreading capacity of the solution 
over the surface of the eye (Liu et al., 2008). 
e) Applications as extended release solid dosage form excipients 
Matrices, more precisely hydrophilic matrices, are simple and efficient systems for controlling 
drug release over extended periods of time from dosage forms. Cellulose ethers, particularly 
HPMC K4M are frequently used to form extended release hydrophilic matrices because of 
fairly good compression properties. Different concentrations of HPMC can be used to control 
or extend the release rate of drugs with a range of solubilities. However, the solubility of the 
drug can affect release profiles (Maderuelo et al., 2011).  
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1.3.3- Polyethylene oxide (PEO) 
Polyethylene oxide (PEO) or Polyox® is a non-ionic, synthetic, hydrophilic, linear, 
homopolymer of ethylene oxide. The monomer is denoted using a formula (CH2CH2O) and the 
polymer might contain up to 3% silicon dioxide. PEO is prepared by the polymerization of 
ethylene oxide with a suitable catalyst (Figure 1.3). Polyox is available commercially  in 
different grades, for example Polyox 301, Polyox 303 and Polyox coagulant are 4,000,000, 
7,000,000 and 5,000,000 respectively (Rowe et al., 2006).  
 
 
Figure 1.3: Represents synthesis of polyethylene oxide using catalyst. 
Commercial PEO is a white, dry and free-flowing powder. It is soluble in water and in a number 
of organic solvents such as chloroform, acetonitrile, toluene and methyl chloride. It can be 
dissolved in both hot and cold water but the polymers will precipitate once the temperature of 
solution is close to the boiling point of water, generally referred to as the cloud point. The cloud 
point depends on the molecular weight, concentration of PEO, concentration of salt and the pH 
value.  The glass transition temperature (Tg) of PEO is -67 °C whereas its melting point ranges 
from 65 °C to 70 °C (Rowe et al., 2006).  
1.3.4- Pharmaceutical applications of polyethylene oxide (PEO) 
Polyethylene oxide has numerous applications in the pharmaceutical industry for a wide range 
of purposes as described below and summarised in Table 1.2. 
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Table 1.2: Summary of pharmaceutical applications of PEO. 
Application Effect Reference 
Bioadhesive material 
 
 
 
Tablet binder 
 
 
Coating agent 
 
 
Viscosity enhancer 
 
 
Controlled release 
excipient 
 
 
Long linear chain structure allows 
PEO to form strong interpenetrating 
network, which results to maintain 
drug release rate. 
 
Binding characteristics of PEO ease 
the process of compaction during 
manufacturing. 
 
Successfully employed to protect 
drugs from moisture, and for taste 
masking  
 
 Acts as suspending agent because of 
its viscosity increasing 
characteristics.  
 
High molecular weight PEO at 
various concentrations has been used 
successfully to control the drug 
release profile. It can be used for 
hydrophilic and hydrophobic drugs. 
Cappello et al., 2006; 
Ma et al., 2014 
Wu et al., 2004 
 
 
Mahalingam et al., 2009 
 
Ma et al., 2014 
 
Maggi et al., 2000 
 
 
 
Maggi et al., 2000 
 
a) Applications as bio-adhesive in hydrophilic matrices 
PEO has a long linear chain structure which enables it to form a strong interpenetrating network 
with mucus leading to potential retention at the site (Ma et al., 2014). Cappello et al., (2006) 
studied the incorporation of PEO into hydroxypropyl-β-cyclodextrin for transmucosal delivery 
of poorly soluble drug carvedilol. The permeation of carvedilol from this system was higher 
and it was concluded that the combination of PEO and cyclodextrins can be employed as a 
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suitable strategy to deliver poorly soluble drugs while maintaining the good mucoadhesion 
properties.  
b) Applications as tablet binder 
PEO can acts as binder in direct compression systems. The good flow and lubrication properties 
of PEO can ease the compression and potentially assist tableting operations (Jones 2004; Rowe 
2006). 
c) Applications in pharmaceutical coating 
Various PEO grades have potential to utilise in as a coating material for pharmaceutical 
manufacturing to overcome the friability and taste issues (Mahalingam et al., 2009). 
d) Viscosity increasing agent 
PEO can be used as a suspending agent because of it has the potential to modify the viscosity 
of the liquid. During successful suspension formulation development, maintaining the product 
viscosity at optimum levels is key factor as a high concentration of polymer can cause gelling 
and physical instability (Ma et al., 2014).  
e) Applications as controlled release solid dosage form excipient 
PEO can be used in various dosage forms, particularly in controlled release tablet systems, for 
instance bioadhesive delivery systems and controlled matrix tablets. Matrices are simple and 
efficient systems for controlling drug release from various dosage forms. PEO, in particular 
high molecular weight PEO, have been suggested by various authors and successfully used in 
pharmaceutical industry over the past decade in controlled release dosage forms. Different 
concentrations can be used to control the drug release profile over the specific period of time 
(Maggi et al., 2000).  
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1.4. Factors affecting swelling/ drug release  
The process of developing compressed hydrophilic matrices might be simple but it becomes 
very complicated and challenging when it comes to explaining the mechanism of drug release 
from these matrices. The physicochemical properties of the polymer and incorporated drug can 
substantially affect the swelling, erosion and drug release kinetics of hydrophilic matrices. 
Some critical factors that can affect swelling, erosion and release of drug are described below 
and summarised in Table 1.3.  
1.4.1- Polymer particle size 
The impact of the particle size of the polymer on drug release has been reported (Dabbagh et 
al., 1996; Viriden et al., 2009 and Caraballo, 2010). The vast majority have concluded that the 
particle size of the polymer does have an impact on drug release but it is complex. Generally, 
smaller polymer particles can initiate rapid gel layer development on the surface of matrix 
tablets that can slow drug release rate. Matrices formulated with polymer particle sizes larger 
than 200 μm can disintegrate before gel layer formation. On the other hand, matrices 
formulated with a particle size less than 150 μm generate the gel layer rapidly preventing 
disintegration of the system and leading to an extended drug release profile (Maderuelo et al., 
2011). 
HPMC K15M matrices, with an average particle size smaller than 113 μm release the drug 
through a combination of diffusion and erosion. However, when the HPMC particle size was 
more than 113 m, an erosion based drug release mechanism dominates. In conclusion, smaller 
polymer particle sizes were most effective in the formation of a homogeneous gel layer as 
compared to lager size polymer (Miranda et al., 2007). 
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Kaialy et al., 2016 studied the effect of PEO concentration and particle size and concluded that 
PEO of particle size less than 180 μm develops a rapidly formed gel layer barrier, which results 
in slower drug release mechanism by diffusion. 
Table 1.3: Comparison of HPMC and PEO properties affecting swelling/ drug release. 
 
Factor 
HPMC PEO HPMC PEO 
Effect References 
 
Particle size 
 
 
 
 
 
 
Viscosity 
 
 
 
 
 
 
Polymer 
concentration 
 
 
 
 
 
 
 
 
Porosity 
 
Particle sizes < 
150 µm are 
effective at 
controlling 
swelling 
 
 
 
Higher the 
viscosity of 
HPMC, the 
greater the 
swelling index. 
 
 
Drug release rate 
decreases as the 
fraction of 
polymer 
increases over 
certain 
percentage. 
 
 
 
 
 
Decreased 
porosity in the   
case of HPMC 
showed 
increased 
swelling rate. 
Smaller particle 
size reduced 
the drug release 
rate.  
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1.4.2- Effect of viscosity 
The viscosity of the polymers is one of the basic parameters that controls drug release and 
determines the mechanism of release. In solution, the viscosity of a polymer depends on the 
chemical structure of the polymer, molecular weight, temperature and the interactions with the 
solvent. Commonly, polymers with high molecular weight increase the viscosity of solutions 
(Daly et al., 1984). 
Various authors have studied the impact of viscosity of HPMC and other related cellulose ether 
based on drug release from hydrophilic matrices. It was concluded that the greater the viscosity 
of a polymer, the faster the swelling and, over time, a physically stable gel layer is formed 
which eventually decreases the drug release (Maderuelo et al., 2011; Ghori and Conway, 2015).   
Likewise, viscosity of PEO can affect drug release, particularly for matrices containing high 
molecular weight polymer as they have the ability of rapid swelling which leads to the 
development of turbid gel layers which resist erosion and therefore potentially lead to slower 
drug release (Maggi et al., 2000). 
The swelling and erosion behaviours of HPMC and PEO depend upon the viscosity of the 
polymer; the higher the viscosity of HPMC and PEO lead to higher swelling while the 
percentage of erosion decreases with increasing viscosity of a polymer. This can be attributed 
to the fact that the ability of higher viscosity polymer to absorb water is greater, which results 
in a rapid swelling (Gao et al., 1996; Hiremath et al., 2008). 
1.4.3- Effect of polymer concentration  
Generally, drug release rate decreases with an increase in the ratio of polymer in the matrix 
tablet. High polymer loads lead to lower porosity of the matrix tablet, which results in lower 
drug release rates (Tiwari et al., 2003; Maderuelo et al., 2011; Ghori and Conway et al., 2015).  
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For example, Ebube et al., (2004) found that an increase in the percentage of cellulose ether 
polymer (3.5% to 19.2%) in the matrix tablet corresponded to a decrease in the drug release 
rate. Similarly, Mitchell et al., (1993) found an increase in the ratio of HPMC and related 
polymers corresponds to a higher degree of polymer chains entanglement. Thus, in turn, 
viscosity decreases and as a result tortuosity of the release pathway increases which causes a 
slower drug release.   
Conversely, there is a difference of opinions as some authors argue that release of highly water 
soluble drugs is not affected by polymer concentration above the critical polymer concentration 
(the minimum concentration require to develop a gel-layer on the surface of the tablet) as 
release rate did not decrease (Ghori 2014). Hydrophilic matrices containing tramadol HCl, a 
highly water soluble drug, were investigated by Tiwari et al., (2003).  There were no significant 
changes in release rate with changes in the polymer concentration. Therefore, it was reported 
that at HPMC concentrations above 20% there is no significant impact on the drug release rate 
(Maderuelo et al., 2011). 
In some cases, PEO has added to formulations to increase the drug release rate. Release of 
metoprolol from ethylcellulose tablets was increased on the addition of PEO (Quinten et al., 
2011) up to a ratio of 70%.  
1.4.4- Effect of porosity 
Porosity will influence the swelling kinetics of hydrophilic matrices thus affecting drug release 
rate. Inclusion of diluents and other materials within the matrix decreases the percentage of 
retardant polymer causing a decrease in the release that is due to higher tortuosity of the gel 
through which the drug diffuses (Lotfipour et al., 2004). 
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In hydrophilic matrices, distribution of pores or channels affects the drug release profile. 
Dabbagh et al., (1996) prepared matrices with different compression forces. All matrices 
prepared at 78.7 mN m˗2 or higher had similar porosities and similar dissolution profiles. On 
the other hand, matrices prepared at compression pressures below 78.7 mN m˗2 had higher 
porosity and faster release rate. On the basis of these observations authors concluded that 
porosity affects release rate 
The phenomenon of pore formation in the matrices of hydrophilic drugs is known, while in the 
case of water- insoluble drugs pore formation is impeded. During release, drug particles close 
to the surface can dissolve rapidly and form pores through which other drug molecules can 
diffuse which ultimately increase the drug release rate. If needing to negate this, the percentage 
of polymer may be increased to enhance physical cross-linking and reduce pore generation, 
however, it some cases the pore formation might be helpful in drug liberation from the 
hydrophilic matrix device (Reza et al., 2003). 
The effect of porosity on release rate was studied for HPMC and PEO matrices.  In the case of 
HPMC based matrices decreased porosity produced a higher swelling rate which might be 
attributed to higher osmotic stress (a sudden change in the solute concentration around a matrix 
tablet, which causes a rapid change in the movement of water across) within the compact 
(Maderuelo et al., 2011; Ma et al., 2014; Ghori and Conway, 2015). 
1.4.5- Effect of compression pressure 
 Compression pressure during tablet manufacturing could be closely related to change in the 
porosity of tablets (Ford et al., 1985; Dahl et al., 1990; Nokhodchi et al., 1996). Apparently, an 
increase in compression pressure had translated into a higher degree of compactness and hence 
a higher apparent density of the matrix, that results in reduced porosity (Hiremath et al., 2004). 
Kabanda et al., 1994 found tablets with different crushing strength had differences in initial 
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release rates but once the polymer had swollen, the dissolution profiles were similar (Velasco 
et al., 1999). In case of PEO, compression pressure has a noticeable influence leading to 
pressure dependant reduction in tablet porosity. Other important factors affecting PEO matrices 
include compression speed, desired shape, size, and physicochemical characteristics of various 
PEO grades. PEO  tablets showed initial burst effect due to variation in compression forces but 
once fully hydrated, the release of drugs became steady (Hiremath et al., 2008).  
1.5- Tabletting and compaction properties of hydrophilic matrices 
Compaction can be defined as the consolidation and compression of powder particles on 
application of pressure. It involves the reduction of bulk volume as the entrapped air during die 
filling leaks out reducing the gaseous phase. It is a mechanical phenomenon under which the 
state of material is changed from powder to a compact having a desired porosity (Ghori & 
Conway 2016). Compressed hydrophilic matrices are material composites which can be 
fabricated using hydrophilic polymers or their mixtures in the presence of API, moreover, other 
pharmaceutical ingredients such as filler, binder and glidant can also be incorporated to aid the 
compaction process (Ghori & Conway 2015). The physicochemical properties of these 
materials can influence the compaction behaviour. Hence, the degree and extent of deformation 
and consolidation of these polymers can influence the compaction pressure attributes that 
include, but are not limited to, porosity, surface roughness, compact internal microstructure 
and interparticulate bonding and packing (Narayan & Hancock 2003). HPMC possesses good 
compaction properties attributed to a relatively high propensity for plastic deformation and 
anti-static behaviour during powder mixing (Ghori et al., 2014b; Ghori et al., 2015; Timmins 
et al., 2014) which assists large surfaces to be in close proximity to each other and a large 
number of bonds, mainly intermolecular forces, to be established between the particles 
(Karehill et al., 1990; Nyström et al., 1993). Additionally, mechanical interlocking may also 
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contribute to the overall strength of these matrix tablets (Karehill et al., 1990). On the other 
hand, PEO is a synthetic hydrophilic polymer is also widely employed for the development of 
hydrophilic matrices also deforms plastically. However, the PEO based matrices have a 
propensity of higher elastic recovery during decompression and ejection. It can readily deform 
even at low pressures and develop soft tablets in relation to HPMC (Yang et al., 1996; Ghori 
et al., 2017a). 
1.6- Rationale, aims and objectives of current research project 
The designing, development and fabrication of successful controlled/sustained release 
formulations require an understanding of polymer chemistry and physicochemical principles 
of pharmaceutics. Factors controlling drug release mechanisms from hydrophilic polymer 
matrices are influenced by the physicochemical properties of polymers. PEO consolidates at 
low pressures and has a tendency to produce soft tablets and that can affect controlled release 
performance (Yang et al., 1996). In contrast, HPMC has a tendency to deform plastically and 
have fairly good compaction properties (Ghori et al., 2017). Mechanistically, both the polymers 
have a tendency to behave differently under compression pressure. Therefore, this research 
project was designed to investigate the swelling, erosion, intra-particulate bonding strength, 
compaction, microstructural and surface roughness properties of PEO WSR N60K and HPMC 
K4M in their native compacted form using a range of compression pressures (50-250 MPa). 
Additionally, 1:1 w/w (HPMC K4M: PEO WSR N60K) mixed polymer matrices will also be 
developed to understand how the polymer hybrid system can have an impact on the 
aforementioned functional properties. Moreover, the interrelationship between the various 
previously mentioned properties has also studied, as depicted in Figure 1.4. 
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Figure 1.4: Schematic illustration of aims and objectives of research project. 
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2- Materials and Methods 
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2. Materials and Methods  
2.1- Materials   
Hydroxypropyl methylcellulose (HPMC K4M) (Methocel K4M) and Polyethylene oxide 
(Polyox WSR N60K) were kindly provided by Colorcon Ltd. (Dartford, UK) and their 
specifications are listed in Table 2.1. 
Table 2.1: Specifications of HPMC K4M and PEO WSR N60K used in the study. 
Material  Methoxy (MeO) 
(% w/w) a 
Hydroxypropyl (HPO)  
(% w/w) a 
Viscosity  
(cps) a 
K4M 22.3 8.5 4351 
WSR N60K - - 4131 
                  a
 Data obtained from the manufacturer (Dow Chemical Co. USA) 
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2.2- Methods 
2.2.1- Particle size fractionation  
Mechanical sieving (Endecotts Ltd. London, United Kingdom) was used to obtained particle 
size fractions of both polymers (75- 125 µm). Briefly, sieves with openings of 125 µm and 75 
µm were employed at the top and middle of the mechanical sieving assembly. The receiver pan 
was attached at the base and it was placed on a sieve shaker (Endecotts Ltd. London, United 
Kingdom). The powder was poured on the top sieve and shaken for 15 mins and the powder 
particles retained on the middle sieve were collected. The same powder was cycled five times 
(n=5) to accurately control the particle size. All powders were stored at ambient temperature 
(22-24°C) and humidity (RH 38-40 %).  
2.2.2- Preparation of polymer powder mixtures 
HPMC K4M and PEO WSR N60K were mixed at 1: 1 w/w. Both polymers were blended and 
mixed for 15 minutes to get a homogeneous mixture using a Turbula shaker-mixer (Glen Mills 
Inc. Clifton, NJ, USA) at 50 rpm. This mixture of polymers was stored in glass containers at 
ambient temperature (22-24°C) and humidity (RH 38-40 %) during the powder mixing 
experiment.  
2.2.3- Particle surface morphology 
The surface morphology of the polymer powders and respective powder mixtures (1:1 w/w) of 
these two polymers was observed using scanning electron microscopy (SEM). Dry powder 
samples were mounted onto stubs using double-sided adhesive tape and were sputter-coated 
with gold/palladium (80:20) for 60 seconds using a Quorum SC7620 Sputter Coater (Quorum 
Technologies, Laughton, UK).  Samples were placed separately on the specimen holder of the 
SEM (Jeol JSM-6060CV, Jeol Inc. Peabody, MA, USA) under vacuum and picture formed was 
observed directly on the computer attached to the system and recorded photographically. 
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2.2.4- Determination of true density of powders 
The true density of solid powders is an intrinsic property and defined as mass per unit volume 
(g cm-3). The true density of both polymers (HPMC K4M, PEO WSR N60K) and their powder 
mixture (1:1 w/w) was determined using AccuPyc 1340 II Pycnometer (Micromeritic UK Ltd. 
Hertfordshire, UK) employing helium as an inert gas. All experiments were performed (n = 
10) to determine the true density. 
2.2.5- Preparation of matrix tablets 
Both polymers and their mixture (50 % w/w) were compressed using a Testometric M500 – 50 
CT (Testometric Company Ltd., Rochdale UK) materials testing machine equipped with a 
13.00 mm Atlas Evacuable Tablet Die (Specac® Limited, UK), Figure 2.1. An analytical 
balance was used to accurately weigh (500 ± 2.5 mg) powder of polymers and their mixture 
and then manually poured into the die. During tablet preparation, two flat- faced punches were 
used on the upper punch and lower punch. The upper punch moved at a speed of 2 mm/min 
during loading and unloading. In this study, five different compression forces (7 kN, 13 kN, 20 
kN, 26 kN and 33 kN) were applied to produce tablets. After ejection, the diameter and 
thickness of all ejected tablets were measured using a digital Vernier calliper. After this, all the 
tablets were stored over silica gel for 24 hours to allow for elastic recovery before any further 
testing was conducted. Temperature and relative humidity during whole compression process 
were in the range of (20-25 °C) and (RH 28-48 %) respectively (Ghori, 2014). 
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Figure 2.1: Testometric material testing machine with 13.00 mm die set. (Image was adapted 
from Ghori 2014).   
2.2.6- Characterisation of matrix tablets 
2.2.6.1- Compact internal micro-texture studies 
The internal micro-texture of compacted matrices was studied using mercury intrusion 
porosimetry (AutoPore IV 9500, Micromeritics, USA). The porosity and its descriptive 
parameters (total intrusion volume, true density, bulk density, absolute density, total pore area 
and average pore diameter) were determined as detailed below. 
The pore diameter (D) was determined using the Washburn equation, Eq. 2.1 (Washburn et al., 
1921).  
𝐷 =
−4 𝛾 cos 𝜃
P
  
Where,   
D = pore diameter (µm)  
γ = surface tension of mercury (485 dyn cm-1) 
𝜃 = contact angle of mercury (130°) 
P = pressure (psia) 
 
Total pore area (A) was determined using Eq. (2.2).  
 
𝐴 =
1
𝛾 cos 𝜃
∫ 𝑃. 𝑑𝑉
   𝑉𝑡𝑜𝑡
0
 
Eq. 2.1 
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Where,  
P = pressure (psia) 
V = intrusion volume (mL g-1).  
Vtot = total intrusion volume (mL g
-1) 
 
Average pore diameter (DA) was calculated using Eq. 2.3.        
𝐷𝐴 =
4 𝑉𝑡𝑜𝑡
𝐴𝑡𝑜𝑡
  
Vtot = total intrusion volume (mL g
-1) 
Atot = total pore area (mL g
-1) 
 
Bulk density (ρb) of tablet was calculated using Eq. 2.4.  
 
𝜌𝑏 =
 𝑊𝑠
𝑉𝑝 − 𝑉𝑚
   
Ws = weight of tablet sample (g)      
Vp = volume of empty penetrometer (mL)  
Vm = volume of mercury (mL) 
 
Apparent density (ρa) of tablet was calculated using Eq. 2.5.   
𝜌𝑎 =
 𝑊𝑠
𝑉𝑠 − 𝑉𝑡𝑜𝑡
   
Where,  
Ws = weight of tablet sample (g)      
Vtot = total intrusion volume (mL g
-1) 
Vs = the volume of penetrometer excluding the mercury volume (mL)   
 
The porosity (ɛ, %) was determined using Eq.  2.6.  
 
 
                                                  Ɛ (%)   = (1 −
𝜌𝑏
𝜌𝑎
 ) ×100      
Where,  
ρb = true density 
ρa = apparent density  
2.2.6.2- Tensile and internal bonding strength analysis of matrices 
After compaction, matrix tablets were left for 24 hours before measuring diameter (D) and 
thickness/height (H). Matrix tablets were broken using a Testometric M500 – 50 CT / Hardness 
Eq. 2.2 
Eq. 2.3 
Eq. 2.4 
Eq. 2.5 
Eq. 2.6 
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Tester (Pharma Test PTB 311E), maximum breaking force (F) was determined, and the tensile 
strength (𝜎𝑋) was calculated using equation Eq. 2.7 (Fell & Newton., 1970).  
                                                                 𝜎𝑋 =
2𝐹
𝜋𝐷𝐻
                            
 
Where;  
 σX  = tensile strength 
 F = tablet breaking force 
 D = tablet diameter 
 H = thickness/height 
 
A Ryshkewitch-Duckworth relationship between the global porosity (Ɛ, %)  and tensile 
strength was determined for every matrix tablet (Duckworth 1953) using Eq. 2.8  
𝑙𝑛 (
𝜎𝑋
𝜎𝑦
) =  −k ×  ɛ 
Where;  
 𝜎𝑋  = Tensile strength 
 𝜎𝑦 = Tensile strength at zero porosity 
 k = Constant referred to as bonding capacity  
 Ɛ = Porosity  
 
2.2.6.3- Surface roughness studies 
The surface roughness studies of all the compacted matrices was studied using atomic force 
microscopy (AFM, Dimension Icon by Bruker, UK). The images were collected using contact 
mode and a standard optical lever method with a small offset of force. The three-dimensional 
root mean square roughness (Sq) (Eq. 2.9) (Blunt & Jiang, 2003; Farris, Introzzi, Biagioni, 
Holz, Schiraldi, & Piergiovanni, 2011; Ghori et al., 2017b) was also determined using 
SURFSTAND® software (University of Huddersfield) (Blunt & Jiang, 2003). The scan area 
was 5 × 5 µm2 and each measurement was carried out in triplicate (n=3).                        
Eq. 2.7 
Eq. 2.8 
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                           𝑆𝑞 = √
1
𝑀𝑁
∑  
𝑁
𝑗=1
∑  
𝑀
𝑖=1
𝑛2 (𝑥𝑖, 𝑦𝑖 )                                
Where,  
𝑥 = horizontal ordinate of line-scan profile at point 𝑖 
𝑦 = vertical ordinate of line-scan profile at point 𝑖 
M = Median of line-scan profile heights 
N = samples size 
 
2.2.6.4- Swelling studies 
The swelling studies were carried out for all the tablets using USP apparatus 1 (Pharmatest 
PTWS D610, Pharmatest Ltd. Hainburg, Germany) at 50 rpm at 37 °C. Tablets were placed in 
pre-weighed baskets made of stainless steel wires and the combined weight determined. Pre-
weighed matrix tablets were then immersed in the dissolution vessel containing 900 mL 
deionised water (swelling medium). After 15 minutes the previously weighed baskets, 
containing hydrated tablets were removed from the vessels, lightly blotted with 125 mm filter 
paper (Whatman®, UK) to remove excess liquid and then re- weighed (Ws). Tablets were 
rapidly replaced back into the medium and the process repeated at 30, 60, 120, 240, 360 and 
720 minutes. The mean weight was determined for each tablet and degree of swelling (S) was 
determined by using Eq. 2.10.  
                                               
Where,    
Wi  =  Initial weight of tablet 
Ws = Swollen tablet weight 
Eq. 2.9 
Eq. 2.10 
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Where Wi initial weight and Ws is swollen matrix tablet weight at immersion time (t) in the 
water (swelling medium). The degree of swelling was determined from the mean of three 
replicates and presented as degree of swelling (S, %) against time (t) 
2.2.6.5- Erosion studies 
Erosion of matrix tablets was determined by a gravimetric technique (Ghori et al., 2014). The 
study was conducted using USP apparatus I (Pharmatest PTWS D610, Pharmatest Ltd. 
Hainburg, Germany) at 50 rpm at 37 °C. The dry tablets were accurately weighed and placed 
in baskets prior to immersion in erosion media (deionised water). Tablets were removed at 15, 
30, 60, 120, 360 and 720 minutes and lightly blotted dry with 125 mm filter paper (Whatman® 
Ltd. UK) to remove excess water. They were subsequently dried in a convection oven at 50°C. 
After 24 hours, the tablets were cooled to ambient temperature and then weighed until a 
constant weight had been achieved and this was termed the dried weight. All studies were 
conducted in triplicate. The degree of erosion (E) was calculated using Eq. 2.11.  
                                                          100


i
fi
W
WW
E                     
Where, Wi is the initial weight of the matrix tablets and Wf is the weight of the dried matrices 
at specific sampling times. 
2.2.6.6- Statistical analysis for interrelationship studies 
Linear regression approach was adopted to model the relationship between the various 
parameters derived from swelling, erosion and tableting. The linearity was studied using R2 
values and R2 >0.90, 0.80-0.89 and <0.80 were considered good, fairly good and weak, 
respectively.  
Eq. 2.11 
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3- Results and Discussion 
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3. Results and discussion 
3.1- Characterisation of powders 
True density is the density (weight per unit volume, g/cm3) excluding the volume of any pores 
or spaces between powder particles. Density imparts significant effects on powder flow and 
compaction, ultimately affecting the quality of compacts. Table 3.1 lists the true density of 
HPMC K4M, PEO WSR N60K and 1:1 w/w mixture of HPMC K4M/PEO WSR N60K. True 
density values of all the powders are quite close to each other but HPMC K4M has the highest 
true density and PEO WSR N60K has the lowest while the density of 1:1 w/w powder mixture 
lies in between the highest and lowest value.  
SEM was carried out to observe the surface morphology of powder particles of HPMC K4M 
and PEO WSR N60K. The SEM image of HPMC K4M in Table 3.1a shows that it comprises 
fibrous aggregates of irregular shape while Table 3.1b shows the aggregates of PEO WSR 
N60K powder particles (Hewlett et al. 2012) and Table 3.1c shows SEM image of 1:1 w/w 
mixture of HPMC K4M and PEO WSR N60K. The red arrow points towards the PEO WSR 
N60K powder particles while green dotted arrow points out the HPMC K4M powder particles. 
Table 3.1: True density of materials (standard deviations are given in parenthesis, n=10)  
 
 
Material HPMC K4M PEO WSR N60K HPMC K4M: PEO WSR N60K (1:1 
w/w) 
𝝆 (g cm-3) 1.33 (0.001) 1.30 (0.01) 1.31 (0.005) 
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Figure 3.1: SEM micrographs of (a) HPMC K4M, (b) PEO WSR N60K and (c) 1:1 w/w 
powder mixture. Green and red arrows represent HPMC and PEO respectively. 
 
3.2- Compaction, microstructural, bonding strength and surface 
roughness studies 
Tablet compaction is a complex process and particulate materials are used to develop 
composites of pharmaceutical tablets. The physical and chemical properties of the particulate 
material affect their compaction behaviour and the final properties of the compact itself (Zhang 
et al., 2003). Generally, during compaction, powders undergo various transitions to form a 
porous solid. Powder (drug/excipient blend) is poured into a die and under a transient force 
profile, powder is compressed. The gradual increase in stress profile allows it to densify and 
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deform the powder bed into a solid compact (Ghori & Conway 2016). Hence, it is of great 
interest to investigate the process of compaction during the development of compressed 
hydrophilic matrices as the pressure exerted to compress the powder of particulate nature can 
be non-uniform, thus, leading to density variation affecting tensile strength, porosity and other 
properties and the compact will exhibit properties depending upon the interactions and bonding 
between particles. These density variations and bonding properties might have significant 
impact on the performance and functionality of the matrix tablets.  
The relationship between tensile strength and compression pressure (Figure 3.2) was studied 
to understand the effect of compression pressure on tensile strength. In general, tensile strength 
has increased with increase in compression pressure. There is a gradual increase in tensile 
strength of HPMC K4M from 50 to 100 MPa. Beyond this pressure, there is a sharp increase 
in tensile strength at 150 MPa and then it again gradually increases at further increased 
pressures. HPMC K4M: PEO WSR N60K (1:1 w/w) also exhibits the same pattern. Overall, 
HPMC K4M has the highest tensile strength and PEO WSR N60K has the lowest while HPMC 
K4M: PEO WSR N60K (1:1 w/w) has medium tensile strength.  
 
 
 
 
 
 
      
  Figure 3.2: Tensile strength profile of matrix tablets with respect to compression.   
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Since the compaction process affects microstructural properties of the matrix tablets (Escudero 
et al., 2010), the effect of compression pressure on bulk and apparent density, porosity and pore 
size  was also studied (Figure3.3 ). Bulk density is the ratio of mass to the bulk volume. 
Figure3.3 shows that, generally, the bulk density has gradually increased with an increase in 
pressure. The bulk densities of HPMC K4M and HPMC K4M: PEO WSR N60K (1:1 w/w) are 
quite close to each other especially at 100, 150 and 200 MPa. However, the bulk density of 
PEO WSR N60K is quite different from that of HPMC K4M and the physical mixture. HPMC 
K4M has the highest bulk density. Conversely, Figure3.3b shows that apparent density, ratio 
of mass to apparent solid volume, have decreased with increase in pressure. At some pressures, 
the apparent densities of HPMC K4M and PEO WSR N60K are close to each other. The 
apparent density of HPMC K4M and HPMC K4M: PEO WSR N60K (1:1 w/w) decreases 
gradually but for PEO WSR N60K initially, there was a sharp decrease from the compression 
pressure of 50 to 100 MPa and then decreases gradually at further increased pressures. HPMC 
K4M and HPMC K4M: PEO WSR N60K (1:1 w/w) has the lowest and highest apparent 
density, respectively.  
The porosity profile of matrix tablets (Figure3.3c) shows that porosity has gradually decreased 
with increase in pressure. For all types of matrix tablets, porosity was highest at 50 MPa and 
lowest at 250 MPa. Overall, PEO WSR N60K has the highest porosity and HPMC K4M has 
the lowest. The porosity of HPMC K4M: PEO WSR N60K (1:1 w/w) lies in between the 
HPMC K4M and PEO WSR N60K.  
It is quite evident from the (Figure3.3d) that average pore diameter sharply decreases when the 
pressure increases from 50 to 100 MPa and then decreases gradually with further increase in 
pressure except for the HPMC K4M where average pore diameter decreases gradually 
throughout the increase in pressure. The average pore diameter of HPMC K4M is the lowest 
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and is highest for PEO WSR N60K while HPMC K4M: PEO WSR N60K (1:1 w/w) based 
matrix tablets has medium sized pores.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: Matrix tablet microstructural profile with respect to compression pressure (a) 
bulk density (b) apparent density (c) porosity (d) average pore diameter. 
 
Moreover, porosity and tensile strength are related to each other as tensile strength affects the 
porosity (Sebhatu et al., 1999; Tye et al., 2005). A graphical representation of porosity versus 
tensile strength is given in Figure 3.4a. Generally, the tensile strength decreased with an 
increase in porosity except for the HPMC K4M that shows quite a different pattern from the 
rest. It is evident from the Figure 3.4a that initially, tensile strength of HPMC K4M increases 
with increase in porosity but starts to decrease when the porosity increases further while Figure 
3.4 b-c show that tensile strength of PEO WSR N60K and HPMC K4M: PEO WSR N60K (1:1 
w/w) decreases gradually with an increase in porosity.  
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The Ryshkewitch-Duckworth relationship (Duckworth 1953), previously described in 
section.2.2.6.2, was used to investigate the relationship between tensile strength and porosity. 
The equation fitting parameters are given in Table 3.2. It is evident that HPMC K4M has the 
highest (3.50) and PEO WSR N60K has the lowest (2.76) interparticulate bonding capacity 
(K). Whereas, the tensile strength capacity of HPMC K4M: PEO WSR N60K (1:1 w/w) lies 
near to the capacity of HPMC K4M.  
 
 
 
 
Figure 3.4: Porosity (ɛ) vs tensile strength relationship for (a) HPMC K4M, (b) PEO WSR 
N60K and (c) HPMC K4M: PEO WSR N60K (1:1 w/w).  
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Table 3.2: Fitting parameters from Ryshkewitch-Duckworth relationship. 
Matrix tablet type Fitting parameters 
 K σy  (MPa) R2 
HPMC K4M 3.50 8.165 0.89 
PEO WSR N60K 2.76 6.04 0.99 
HPMC K4M:PEO WSR 
N60K (1:1 w/w) 
3.33 7.33 0.99 
 
To characterise the topography of matrix tablets, surface roughness can be used to determine 
favourable compression attributes (porosity, tensile strength, surface roughness and 
interparticulate bonding capacity) of hydrophilic polymers which are might be important for 
successful formulation development (Narayan & Hancock 2003; Ghori et al., 2017). As 
previously mentioned, compacts are composites of various particles that have surface 
roughness values which are characteristic of the configuration of their particulate components. 
As a result, the degree of surface roughness may influence other factors (powder particle 
bonding and packing) of matrix tablets (Narayan & Hancock 2005).  
The values of three dimensional root mean square roughness of all types of matrix tablet were 
determined by using a quantitative method, atomic force microscopy (AFM). AFM allows data 
acquisition at very high resolution towards the molecular level. The 3D AFM images of matrix 
tablet surfaces can be seen in Figure 3.5 - Figure 3.7. It can be seen that increase in compression 
pressure has a noticeable effect on surface roughness of the matrix tablets i.e. the surface of the 
matrix tablets matrix has decreased or in other words, it has become smoother with increase in 
compression pressure. Figure 3.5 shows that the surface of HPMC K4M based matrix tablets 
was rough at lower pressure but with increase in pressure, the surface became smoother. The 
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surface of these tablets is smoother at 250 MPa as compared to the other compression pressures. 
PEO WSR N60K and HPMC K4M: PEO WSR N60K (1:1 w/w) also exhibited the same pattern 
Figure 3.6 - Figure 3.7. Overall, the surface of HPMC K4M based matrix tablets are smoother 
at higher compression pressures followed by HPMC K4M: PEO WSR N60K (1:1 w/w) and 
PEO WSR N60K.  
The surface roughness profile of matrix tablets with respect to compression pressure (Figure 
3.8) shows that surface roughness of all types of matrix tablets has decreased gradually with 
increase in compression pressure. PEO WSR N60K has the highest surface roughness and 
HPMC K4M has the lowest. Surface roughness of HPMC K4M: PEO WSR N60K (1:1 w/w) 
lies close to that of HPMC K4M at initial compression pressures but at higher compression 
pressures more closely resembles that of PEO WSR N60K.  
 
 
Figure 3.5: AFM surface topographical images of HPMC K4M matrix tablets (a) 50 MPa (b) 
100 MPa (c) 150 MPa (d) 200 MPa and (e) 250 MPa. 
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Figure 3.6: AFM surface topographical images of PEO WSR N60K matrix tablets (a) 50 
MPa (b) 100 MPa (c) 150 MPa (d) 200 MPa and (e) 250 MPa. 
 
 
 
Figure 3.7: AFM surface topographical images of HPMC K4M: PEO WSR N60K (1:1 w/w) 
matrix tablets (a) 50 MPa (b) 100 MPa (c) 150 MPa (d) 200 MPa and (e) 250 MPa. 
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Figure 3.8: Surface roughness profiles of matrix tablets with respect to compression 
pressure. 
 
3.3- Swelling and erosion studies  
The rate of liquid uptake determines the extent of swelling of hydrophilic matrices. Polymer-
liquid interaction was investigated using liquid uptake studies.  The matrix tablets were 
immersed in swelling media (de-ionised water) at 37 °C and their response with respect to time 
is shown in Figure 3.9 a-c, in terms of weight increase (% Swelling, S) due to penetration of 
liquid. When the aforementioned polymeric matrices were exposed to liquid, at first, wetting 
occurs at the surface and then gradually progresses through the matrix network. The Tg  
decreases as the liquid penetrates and as it becomes equal to the temperature of the system (37 
°C) it allows the polymeric chains to relax and the penetrant liquid starts acting as a plasticiser 
(Wan et al., 1995; Viridén et al., 2009). As a result, a viscous so-called gel layer starts to appear 
across the matrix tablet surface. Moreover, another phenomenon causing the matrices to swell 
is the osmotic stress applied on the middle region that is located between the inner dry core and 
the outer gel layer present around the matrix tablet.  
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A swelling kinetic model known as the Vergnaud (Vergnaud 1993) model was adopted to 
evaluate the rate and mechanism of swelling of hydrophilic matrices used in this study. This 
method has been used by various authors to evaluate the swelling kinetics and its equation can 
be expressed as Eq. 3.1.  
                                                M = Kw tn                  (Eq. 3.1) 
Where, M is the amount of liquid transferred, t is time, Kw is the swelling rate constant and n 
is the exponent indicating the mechanism of water uptake. The characteristic values of the 
model were calculated by putting the values in Eq. 3.1 and the results obtained are listed in 
Table 3.3.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9: Swelling profiles of (a) HPMC K4M, (b) PEO WSR N60K and (c) 1:1 w/w 
(HPMC K4M: PEO WSR N60K) based matrices. 
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 Table 3.3: Swelling and erosion kinetic parameters (n=3). 
Polymer 
Compression 
pressure (MPa) 
Swelling kinetics parameters 
Matrix erosion 
parameters 
  KW n R2 KE R2 
HPMC K4M 
50 29.19 0.3314 0.990 0.032 0.999 
100 35.37 0.3166 0.998 0.024 0.997 
150 50.12 0.2831 0.998 0.018 0.993 
200 49.74 0.2879 0.995 0.017 0.994 
250 49.98 0.2855 0.996 0.017 0.996 
PEO WSR N60K 
50 24.37 0.3487 0.997 0.043 0.975 
100 28.51 0.3328 0.992 0.025 0.951 
150 38.49 0.3026 0.993 0.023 0.947 
200 39.13 0.3014 0.992 0.023 0.941 
250 41.54 0.3000 0.990 0.023 0.963 
(1:1 w/w) HPMC 
K4M:PEO WSR N60K 
 
50 27.83 0.3335 0.992 0.036 0.982 
100 31.19 0.3281 0.996 0.027 0.961 
150 43.74 0.2924 0.995 0.023 0.956 
200 42.93 0.294 0.990 0.022 0.966 
250 42.41 0.2932 0.989 0.021 0.957 
 
The water uptake data exhibited a good fit to the model with the resultant R2 values between 
0.989-0.990. Ebube et al.  (1997) reported that a value of n < 0.5 is indicative of diffusion-
controlled mechanism in which the rate of diffusion is much slower than the rate of polymer 
hydration in a matrix tablet. However, when n = 1, water diffuses through the matrix at a 
constant velocity with an advancing liquid front marking the limit of liquid penetration into the 
matrix. A value of 0.45 < n < 1 indicates anomalous behaviour in which diffusion of liquid and 
polymer hydration are of similar magnitude. As the swelling exponent (n) values for all the 
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types of matrices were lower than 0.5 it can be assumed that the kinetics of swelling or water 
uptake by the matrices follow a diffusion-controlled mechanism.  
In hydrophilic polymeric systems, the outer viscous gel layer, formed by the polymeric carrier 
present on the surface of the matrix tablet, subsequently undergoes erosion over time (Ghori et 
al., 2014a). The outer gel layer controls the overall erosion rate. This gel layer potentially acts 
as a barrier that minimises the swelling and subsequently increases polymer dissolution (Ghori 
et al., 2017). Erosion studies were also carried out on the aforementioned matrix tablets. These 
matrix tablets were accurately weighed before immersing in swelling media (de-ionised water) 
at 37 °C. Tablets were removed from swelling media at specific intervals of time to place in 
the oven and after being dried these tablets were re-weighed. A graph was plotted to show the 
degree of matrix erosion (% erosion as a function of time) and a simple linear regression model 
was applied representing slope as an erosion rate (KE, % min
-1). All the erosion kinetics 
parameters are summarised in Table 3.3 (Ghori et al., 2014a).  
It is evident from the swelling profiles (Figure 3.9) that the compression pressure can 
potentially affect the extent of swelling. The trend was quite similar, which is that increases in 
overall swelling is noticeable with increasing pressure up to 150 MPa. It is quite evident from 
the Figure 3.9 that the swelling of HPMC K4M based matrices was lowest at 50 MPa but started 
to increase as the pressure increased to 100 and 150 MPa. However, beyond this compression 
pressure, any further increase in pressure had a negligible effect on swelling. Additionally, it 
can be seen that the HPMC K4M based matrices has the highest while the PEO WSR N60K 
matrices had lowest swelling and the trend of the swelling in current study was PEO WSR 
N60K < HPMC K4M:PEO WSR N60K (1:1 w/w) <   HPMC K4M. Further, it can be inferred 
from the swelling kinetic data given in Table 3.3 that the order of swelling rate was PEO WSR 
N60K < HPMC K4M: PEO WSR N60K (1:1 w/w) < HPMC K4M. PEO WSR N60K based 
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matrix tablets had the lowest swelling rates and the tablets containing HPMC K4M had highest 
swelling rates, with the mix having rates between these extremes. The swelling exponent (n) 
values for all types of matrix tablets was less than 0.5 which revealed that swelling or water 
uptake by matrix tablets follows a diffusion-controlled mechanism.  
From these findings, it could be suggested that in the case of HPMC K4M and HPMC K4M: 
PEO WSR N60K (1:1 w/w) based matrices the increase in the compression pressure up to a 
certain limit (150 MPa) increased the swelling to its maximum but after that limit further 
increase in pressure could not maximise the swelling any further. However, in the case of PEO 
WSR N60K the swelling rate increases with increasing compression pressure over the range 
studied. Erosion profiles of all matrix tablets Figure 3.10 showed that compression pressure 
has affected the erosion in the same way as it has affected the swelling but in the opposite 
pattern, which is, the degree of erosion decreases with increase in pressure to a certain limit 
that is again similar 150 MPa. The degree of erosion for all types of matrices was highest at 50 
MPa but started to decrease as the pressure increased to 100 and 150 MPa.  However, beyond 
this compression pressure, further increase in pressure had negligible effect on degree of 
erosion irrespective of polymer type used in this research project.  Erosion kinetic parameters 
given in Table 3.3 shows that resultant R2 values range from 0.941-0.999 and KE of all types 
of matrix tablets was highest at 50 MPa but started to decrease with increase in pressure up to 
150 MPa. At higher compression pressure of 200 and 250 MPa, further decrease in erosion rate 
was not observed and in case of HPMC K4M and PEO WSR N60K, it was constant at higher 
pressures of 200 and 250 MPa. Overall, HPMC K4M has the lowest erosion rate followed by 
HPMC K4M: PEO WSR N60K (1:1 w/w) and PEO WSR N60K and the trend of erosion in 
this study was HPMC K4M < HPMC K4M: PEO WSR N60K (1:1 w/w) < PEO WSR N60K.  
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It could be suggested that increase in compression pressure up to a certain limit (150 MPa) 
decreases the erosion rate to its minimum but after that limit further increase in pressure could 
not minimise the erosion any further.  
 
 
 
 
 
Figure 3.10: Erosion profiles of (a) HPMC K4M, (b) PEO WSR N60K and (c) 1:1 w/w 
(HPMC K4M: PEO WSR N60K) based matrices. 
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3.4- Inter-relationship studies  
3.4-1. KE vs KW 
Inter-relationship of swelling and erosion rate of (a) HPMC K4M (b) PEO WSR N60K and (c) 
1:1 w/w (HPMC K4M: PEO WSR N60K) based matrices at different compression pressures is 
shown in Figure 3.11. It is evident that the erosion rate has decreased with an increase in 
swelling rate. At initial compression pressures, there was a sharp decrease in the erosion rate 
but at higher pressures, there was a gradual decrease. The R2 values of this linear relationship, 
for all types of matrix tablets are given in Table 3.4. The R2 value of HPMC K4M and HPMC 
K4M: PEO WSR N60K (1:1 w/w) shows a fairly good relationship between swelling and 
erosion rate. However, the R2 value of PEO WSR N60K shows a weak relationship. 
 
 
 
 
 
 
 
 
 
Figure 3.11: Inter-relationship of swelling and erosion rate of (a) HPMC K4M (b) PEO WSR 
N60K and (c) 1:1 w/w (HPMC K4M: PEO WSR N60K) based matrices at different 
compression pressures. 
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Table 3.4: Resultant correlation co-efficient (R2) values of inter-relationship studies. 
 
3.4-2. KE vs Sq 
It is evident from Figure 3.12 that erosion rate increases initially with increase in surface 
roughness but at higher compression pressures a sharp and sudden increase can be noticed. The 
resultant values Table 3.4 of HPMC K4M shows a good relationship; and for HPMC K4M: 
PEO WSR N60K (1:1 w/w) it shows a fair relationship while the R2 value of PEO WSR N60K 
shows there is a weak relationship between erosion and surface roughness. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12:  Inter-relationship of surface roughness and erosion rate of (a) HPMC K4M (b) 
PEO WSR N60K and (c) 1:1 w/w (HPMC K4M: PEO WSR N60K) based matrices at 
different compression pressures. 
Relationship type R2 
 HPMC K4M PEO WSR N60K 
HPMC K4M : PEO 
WSR N60K (1:1 
w/w) 
KE vs KW 0.85 0.65 0.83 
KE vs Sq 0.90 0.57 0.89 
KE vs Da 0.95 0.74 0.92 
KW vs Sq 0.83 0.93 0.87 
KW vs Da 0.85 0.99 0.96 
Sq vs Da 0.96 0.91 0.96 
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3.4-3. KE vs Da 
The relationship graph between erosion rate and average diameter (Figure 3.13) shows erosion 
rate and pore diameter are directly related to each other i.e. erosion rate decreases with decrease 
in pore diameter. R2 value Table 3.4 of HPMC K4M and HPMC K4M: PEO WSR N60K (1:1 
w/w) shows a good relationship while R2 value of PEO WSR N60K shows a weak relationship 
between erosion rate and pore diameter. 
 
 
 
 
 
 
 
 
Figure 3.13: Inter-relationship of average pore diameter and erosion rate of (a) HPMC K4M 
(b) PEO WSR N60K and (c) 1:1 w/w (HPMC K4M:PEO WSR N60K) based matrices at 
different compression pressures. 
3.4-4. Kw vs Sq 
Figure 3.14 shows that surface roughness of the tablet has decreased with increase in swelling 
rate, which indicates an inverse relationship between these two parameters. The resultant value 
(Table 3.4) of PEO WSR N60K shows a good relationship and for that of HPMC K4M and 
HPMC K4M: PEO WSR N60K (1:1 w/w) the R2 value shows a fairly good relationship 
between swelling rate and surface roughness. 
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Figure 3.14: Inter-relationship of surface roughness and swelling rate of (a) HPMC K4M (b) 
PEO WSR N60K and (c) 1:1 w/w (HPMC K4M:PEO WSR N60K) based matrices at 
different compression pressures. 
 
3.4-5. Kw vs Da 
Average pore diameter decreased with increase in swelling rate indicating an inverse 
relationship between these two parameters (Figure 3.15). The resultant values given in (Table 
3.4) shows that PEO WSR N60K and HPMC K4M: PEO WSR N60K (1:1 w/w) has a good 
relationship while HPMC K4M has a fairly good relationship.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15: Inter-relationship of average pore diameter and swelling rate of (a) HPMC K4M 
(b) PEO WSR N60K and (c) 1:1 w/w (HPMC K4M:PEO WSR N60K) based matrices at 
different compression pressures. 
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3.4-6. Sq vs Da 
There is a direct relationship between surface roughness and average pore diameter, i.e., surface 
roughness decreases as pore diameter decreases (Figure 3.16). The resultant values (Table 3.4) 
show that all types of matrix tablets show a good relationship between surface roughness and 
average pore diameter. 
 
 
 
 
 
 
 
 
 
Figure 3.16: Inter-relationship of average pore diameter and surface roughness of (a) HPMC 
K4M (b) PEO WSR N60K and (c) 1:1 w/w (HPMC K4M:PEO WSR N60K) based matrices 
at different compression pressures. 
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4- Conclusions  
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4. Conclusions  
The results show that compression pressure significantly affects the tensile strength, bulk and 
apparent density, porosity and pore size of all types of matrix tablets. The physical and 
chemical properties of the particulate material affect their compaction behaviour and the final 
properties of the compact itself. The pressure during compaction was non-uniform resulting in 
density variation affecting tensile strength, porosity and other properties and the compact 
exhibited properties depending upon the interactions and bonding between particles. It is quite 
evident from the results that these density variations and bonding properties have significant 
impact on the swelling and erosion properties of matrix tablets.  
HPMC K4M: PEO WSR N60K (1:1 w/w) has medium tensile strength and pore size. The 
porosity of HPMC K4M: PEO WSR N60K (1:1 w/w) lies in between that of compacts of 
HPMC K4M and PEO WSR N60K. The interparticulate bonding capacity of HPMC K4M: 
PEO WSR N60K (1:1 w/w) lies near to the capacity of HPMC K4M. It is concluded from the 
findings presenting in this thesis that porosity and tensile strength are related to each other as 
tensile strength affects the porosity. Moreover, the results show that compression pressure does 
affect the swelling and degree of erosion of matrix tablets but in case of HPMC K4M and 
HPMC K4M: PEO WSR N60K (1:1 w/w) it is imperceptible beyond 150 MPa compression 
pressure. Moreover, an interrelationship of all the derived compaction attributes showed a 
relationship with swelling and erosion kinetic parameters. Finally, on the basis of these findings 
it can be concluded that the tableting attributes can potentially impact the performance and 
functionally of hydrophilic matrices. Moreover, the information extracted from the current 
study can be used in the future to develop and adopt strategies for development and further 
optimization of compressed hydrophilic matrices. 
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5- Future Works 
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5. Future Works  
There are many areas of potential prospects to expand this work, including; 
1. To study the impact of these tableting attributes on the release kinetics of drugs 
having different solubility characteristics.  
2. To study the impact of fasted and fed conditions on the performance and 
functionality of these matrices.  
3. To extrapolate this study to other polymers.  
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